跳至主要内容
临床试验/ACTRN12612000252819
ACTRN12612000252819终止4 期

A Randomised Controlled trial of intravenous immunoglobulin (IVIg) compared with pulse methyl-prednisolone in Renal Transplant recipients with chronic active antibody mediated rejection to determine histological change on biopsy

Dr William Mulley0 个研究点目标入组 30 人开始时间: 2012年2月29日最近更新:

试验速览

阶段
4 期
状态
终止
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Renal transplant recipient
  • >6 months post-transplant
  • Biopsy evidence of cAMR defined by
  • - Activity - Peritubular capillaritis >10% and/or glomerulitis (g1 or greater)
  • - Chronic Changes - Transplant glomerulopathy or IFTA or peritubular capillary basement membrane multi-lamellation or fibrous intimal thickening of arteries.
  • Evidence of antibody activity
  • - DSAb and/or
  • - Positive C4d staining

排除标准

  • Damage to extensive
  • - IFTA >50%
  • - eGFR <25ml/min
  • - proteinuria >3gm/day
  • Too aggressive
  • - Banff PTC score =3
  • - Vascular rejection
  • Concomitant biopsy findings
  • - Recurrent or de novo GN
  • - Diabetic nephropathy
  • - Interstitial nephritis

研究者

发起方
Dr William Mulley

相似试验